Home Latest Articles
Latest Articles
  • Weiyi LU, Lingmei LI, Na LUO
    Chinese Journal of Pharmaceuticals. 2022, 53(8): 1192-1195.

    The seal integrity of plastic flexible bags containing water for injection was investigated by the submerged bubble method. The application of submerged bubble method in the seal integrity of the large-volume plastic flexible bag packaging system was verified by setting different pressure parameters(6.9, 20.7, and 41.4 kPa) and preparing capillary positive samples(inner diameters of 5, 10, 15, 20, and 30 μm) with different defect sizes. The results showed that the capillary positive sample with the inner diameter of 15 μm could be regarded as the detection limit of the submerged bubble method under the pressure of 41.4 kPa for 15 s, and the average pore size of this positive sample was 3 μm. The sample test results showed that no leak greater than 3 μm was observed in fifty plastic flexible bags packed with water for injection. The submerged bubble method is easy to operate, and the results are reliable, which can detect and locate the leak of the packaging system, and also provide a reference for the application of this method in the plastic flexible bag packaging system.

  • Huijuan XU, Jiaqiu DU, Liang ZHONG, Xiaoyan ZHANG, Chenghao TAO
    Chinese Journal of Pharmaceuticals. 2022, 53(8): 1196-1200.

    The freeze-dried cakes of commercially available vancomycin hydrochloride for injection are easy to stratify and crystallize. Different annealing temperatures(–5 and –10 ℃) groups and different prefreezing rates(6 and 0.5 ℃/min) groups were set and compared in this study. It was confirmed that both adding an annealing step and speeding the prefreezing rate could obviously improve the cake appearance of the freeze-dried products. However, at a higher annealing temperature, some crystalline substances were found in the bottom layer of the sample. And the positions of characteristic peaks(9.76, 17.36, 18.80, 20.49, 21.18, 24.76 and 25.28 °) for these crystals were corresponding to the positions of characteristic peaks of mannitol. The possible reason for this phenomenon was the transformation of amorphous mannitol in the bottom layer to crystalline state at a higher annealing temperature. Therefore, it was not advisable to choose a higher annealing temperature.

  • Yijing HAN, Jue GAN
    Chinese Journal of Pharmaceuticals. 2022, 53(8): 1201-1208.
  • Zhibo LUO, Guilong ZHU, Juyan LIU, Jun YANG, Yingxia BAO, Jiansong WANG
    Chinese Journal of Pharmaceuticals. 2022, 53(8): 1209-1216.
  • Feng GUO, Shaokun ZHANG, Lingxia XU, Wanfu SU, Lin LU
    Chinese Journal of Pharmaceuticals. 2022, 53(8): 1217-1221.
  • Sijin WANG, Ganggang WANG, Meng YU, Shihong MA
    Chinese Journal of Pharmaceuticals. 2022, 53(8): 1222-1226.
  • Jun DONG, Xuyu CHAI, Jian WANG
    Chinese Journal of Pharmaceuticals. 2022, 53(7): 925-934.

    Gastroretentive drug delivery system(GRDDS) can reduce the frequency of administration and improve the efficacy by prolonging the residence time of drugs in the stomach through physical and chemical effects. However, the real retention effect in human body is often affected by individual differences, physiology, diet and other factors, so it is difficult to achieve the stable gastric retention of more than 24 h in the real sense. Ultra-long-acting GRDDS is one of the unique innovative breakthroughs in the field of oral formulations in recent years. Through the subversive design of mechanical changes(stellate structure and spring coil), ultra-long-acting GRDDS greatly enhances the ability to resist the destruction of stomach physiological factors, making it possible to realize stable gastric retention for more than 24 h or even up to 1 month. If it can be further improved in safety and quality, ultra-long-acting GRDDS will make a great breakthrough in the field of oral preparations. In this paper, the development of ultra-long-acting GRDDS in recent years is reviewed, and its technical challenges and application prospects are analyzed and prospected.

  • Jie GAO, Qi ZHANG, Wenzhe WU
    Chinese Journal of Pharmaceuticals. 2022, 53(7): 935-942.

    In recent years, pulmonary inhalation of drug-loaded liposomes has attracted extensive attention due to its unique release characteristics and clinical values. This review introduces the advantages of inhaled liposomes, such as reducing the irritation of drugs to lung tissue and extending the retention time of drugs in the lung. Furthermore, the commonly used liposome preparation technologies(e.g., crossflow technology) and the inhalation methods are emphatically described. Then, the marketing and clinical situations of liposome inhalation preparations are briefly introduced. It is hoped to provide literature support for the study of the liposome pulmonary inhalation route for administration.

  • Weicheng ZHOU, Pengfei YUE, Fangfang LEI, Yingchong CHEN, Ming YANG
    Chinese Journal of Pharmaceuticals. 2022, 53(7): 943-952.

    Drug-in-CD-in-liposome(DCL) is a new drug delivery system that encapsulates cyclodextrin inclusion complexes into liposomes, so it combines the advantages of the two drug delivery systems. DCL can effectively avoid the leakage and rapid release of lipophilic drugs incorporated in the membrane bilayers, which is beneficial to maintain the integrity of liposomes. The dual protection of cyclodextrin and liposome can drastically improve the stability of light-sensitive and heat-sensitive drugs. It allows better control of the release behaviors of drugs and improves the therapeutic effect of drugs. DCL has a wide range of applicable drugs and shows promising properties for applications. This paper reviews the classification, preparation methods, characteristics, and application progress of DCL in drug delivery, which provides methods and references for developing DCLs as a drug delivery system.

  • Xiaoping FANG, Yi HU, Shan LU, Yan CAO
    Chinese Journal of Pharmaceuticals. 2022, 53(7): 953-961.

    In recent years, the co-amorphous drug formulations have gradually become a new type of drug delivery system with great potential. Co-amorphous drug formulations can improve the stability of amorphous drugs and improve the solubility and dissolution of poorly water-soluble drugs, thereby potentially improving their bioavailability and therapeutic effects. This paper reviews co-amorphous drugs from the perspectives of preparation methods, physicochemical properties, physical stability, and in vitro performance, and clarifieds the in vivo advantages of co-amorphous drugs through a review of the pharmacokinetics of several classic drugs. In particular, the advantages of co-amorphous drugs in theory, preparation technology, and physicochemical properties are discussed to provide a reference for the further development of high-quality co-amorphous drug formulations.

News